Page 347 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 16 Supportive Care for the Cancer Patient 325

252. Ogilvie GK, Walters LM, Fettman MJ, et al.: Energy expenditure 276. Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, et al.: Fruit
in dogs with lymphoma fed two specialized diets, Cancer 71:3146– and vegetable consumption is inversely associated with having pan-
3152, 1993. creatic cancer, Cancer Causes Control 22:1613–1625, 2011.
VetBooks.ir 253. Ogilvie GK, Walters LM, Salman MD, et al.: Resting energy 277. Magalhães B, Peleteiro B, Lunet N: Dietary patterns and colorec-
tal cancer: systematic review and meta-analysis, Eur J Cancer Prev
expenditure in dogs with nonhematopoietic malignancies before
and after excision of tumors, Am J Vet Res 57:1463–1467, 1996.
21:15–23, 2012.
254. Mazzaferro EM, Hackett TB, Stein TP, et al.: Metabolic alterations 278. Sonnenschein EG, Glickman LT, Goldschmidt MH, et al.: Body
in dogs with osteosarcoma, Am J Vet Res 62:1234–1239, 2001. conformation, diet, and risk of breast cancer in pet dogs: a case-
255. Ogilvie GK, Walters L, Salman MD, et al.: Alterations in carbohy- control study, Am J Epidemiol 133:694–703, 1991.
drate metabolism in dogs with non hematopoietic malignancies, 279. Shofer FS, Sonnenschein EG, Goldschmidt MH, et al.: Histopath-
Am J Vet Res 58:277–2281, 1997. ologic and dietary prognostic factors for canine mammary carci-
256. Vail DM, Ogilvie GK, Wheeler SL, et al.: Alterations in carbohy- noma, Breast Cancer Res Treat 13:49–60, 1989.
drate metabolism in canine lymphoma, J Vet Int Med 4:8–11, 1990. 280. Pérez Alenza D, Rutteman GR, Peña L, et al.: Relation between
257. Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al.: Effect of fish habitual diet and canine mammary tumors in a case-control study,
oil, arginine, and doxorubicin chemotherapy on remission and sur- J Vet Intern Med 12:132–139, 1998.
vival time for dogs with lymphoma: a double-blind, randomized 281. Raghavan M, Knapp DW, Bonney PL, et al.: Evaluation of the
placebo-controlled study, Cancer 88:1916–1928, 2000. effect of dietary vegetable consumption on reducing risk of tran-
258. Ogilvie GK, Ford RB, Vail DM, et al.: Alterations in lipoprotein sitional cell carcinoma of the urinary bladder in Scottish Terriers,
profiles in dogs with lymphoma, J Vet Intern Med 8:62–66, 1994. J Am Vet Med Assoc 227:94–100, 2005.
259. Ackerman BH, Kasbekar N: Disturbances of taste and smell 282. Dennart G, Zwahlen M, Vinceti M, et al.: Selenium for preventing
induced by drugs, Pharmacotherapy 17:482–496, 1997. cancer, Cochrane Database Syst Rev 11:CD005195, 2011.
260. Weeth LP, Fascetti AJ, Kass PH, et al.: Prevalence of obese dogs in 283. Wu K, Erdman JW, Schwartz SJ: Plasma and dietary carotenoids,
a population of dogs with cancer, Am J Vet Res 68:389–398, 2007. and the risk of prostate cancer: a nested case-control study, Cancer
261. Tisdale MJ: Are tumoral factors responsible for host tissue wasting Epidemiol Biomarkers Prev 13:260–269, 2004.
in cancer cachexia? Future Oncol 6:503–513, 2010. 284. Bendich A: From 1989 to 2001: what have we learned about the
262. Penna F, Minero VG, Costamagna D, et al.: Anti-cytokine strat- “biological actions of beta-carotene”? J Nutr 134:225S–230S,
egies for the treatment of cancer-related anorexia and cachexia, 2004.
Expert Opin Biol Ther 10:1241–1250, 2010. 285. Cooper DA: Carotenoids in health and disease: recent scientific
263. Seruga B, Zhang H, Bernstein LJ, et al.: Cytokines and their rela- evaluations, research recommendations and the consumer, J Nutr
tionship to the symptoms and outcome of cancer, Nat Rev Cancer 134:221S–224S, 2004.
8:887–899, 2008. 286. Deeb KK, Trump DL, Johnson CS: Vitamin D signaling pathways
264. Pajak B, Orzechowska S, Pijet B, et al.: Crossroads of cytokine in cancer: potential for anticancer therapeutics, Nature Rev Canc
signaling--the chase to stop muscle cachexia, J Physiol Pharmacol 7:684–700, 2007.
59(Suppl 9):251–264, 2008. 287. Abbas S, Linseisen J, Slanger T, et al.: Serum 25- hydroxyvitamin
265. Fearon KC: Cancer cachexia and fat-muscle physiology, N Engl J D and risk of post-menopausal breast cancer-results of a large case-
Med 365:565–567, 2011. control study, Carcinogenesis 29:93–99, 2007.
266. Merlo A, Rezende BC, Franchini ML, et al.: Serum C-reactive pro- 288. Yin L, Grandi N, Raum E, et al.: Meta-analysis: longitudinal stud-
tein concentrations in dogs with multicentric lymphoma undergo- ies of serum vitamin D and colorectal cancer risk, Aliment Pharma-
ing chemotherapy, J Am Vet Med Assoc 230:522–526, 2007. col Ther 30:113–125, 2009.
267. Tecles F, Caldín M, Zanella A, et al.: Serum acute phase protein 289. How KL, Hazewinkel HA, Mol JA: Dietary vitamin D dependence
concentrations in female dogs with mammary tumors, J Vet Diagn of cat and dog due to inadequate cutaneous synthesis of vitamin D,
Invest 21:214–219, 2009. Gen Comp Endocrinol 96:12–18, 1994.
268. Baez JL, Michel KE, Sorenmo K, Shofer FS: A prospective investi- 290. Wakshlag JJ, Rassnick KM, Malone EK, et al.: Cross sectional
gation of the prevalence and prognostic significance of weight loss study to investigate the association between serum vitamin D
and changes in body condition in feline cancer patients, J Feline and cutaneous mast cell tumours in Labrador retrievers, Br J Nutr
Med Surg 9:411–417, 2007. 106:S60–S63, 2011.
269. Caccialanza R, Cereda E, De Lorenzo F, Farina G, Pedrazzoli 291. Selting KA, Sharp CR, Ringold R, et al.: Serum 25-hydroxyvitamin
P, AIOM-SINPE-FAVO Working Group: To fast, or not to fast D concentrations in dogs - correlation with health and cancer risk,
before chemotherapy, that is the question, BMC Cancer 18:337, Vet Comp Oncol 14:295–305, 2016.
2018. 292. Binkley N, Carter GD: Toward clarity in clinical vitamin D sta-
270. Simone BA, Palagani A, Strickland K, et al.: Caloric restriction tus assessment: 25(OH)D assay standardization, Endocrinol Metab
counteracts chemotherapy-induced inflammation and increases Clin North Am 46:885–899, 2017.
response to therapy in a triple negative breast cancer model, Cell 293. Sempos CT, Heijboer AC, Bikle DD, et al.: Vitamin D assays and
Cycle 7:1536–1544, 2018. the definition of hypovitaminosis D: results from the First Interna-
271. Wolin KY, Carson K, Colditz GA: Obesity and cancer, Oncologist tional Conference on Controversies in Vitamin D, Br J Clin Phar-
15:556–565, 2010. macol 84:2194–2207, 2018.
272. Roberts DL, Dive C, Renehan AG: Biological mechanisms linking 294. Young LR, Backus RC: Oral vitamin D supplementation at five
obesity and cancer risk: new perspectives, Ann Rev Med 61:301– times the recommended allowance marginally affects serum
316, 2010. 25-hydroxyvitamin D concentrations in dogs, J Nutr Sci 5:e31,
273. Calle EE, Rodriguez C, Walker-Thurmond K, et al.: Overweight, 2016.
obesity, and mortality from cancer in a prospectively studied cohort 295. Lund EM, Armstrong PJ, Kirk CA, et al.: Prevalence and risk fac-
of U.S. adults, N Eng J Med 348:1625–1638, 2003. tors for obesity in adult cats from private US veterinary practices,
274. Lichtman MA: Obesity and the risk for a hematological malig- Int J Appl Res Vet Med 3:88–96, 2005.
nancy: leukemia, lymphoma, or myeloma, Oncologist 15:1083– 296. Lund EM, Armstrong PJ, Kirk CA, et al.: Prevalence and risk fac-
1101, 2010. tors for obesity in adult dogs from private US veterinary practices,
275. de Boer EJ, Slimani N, van ‘t Veer P, et al.: The European Food Int J Appl Res Vet Med 4:177–186, 2006.
Consumption Validation Project: conclusions and recommenda- 297. Inui A: Cancer anorexia-cachexia syndrome: current issues in
tions, Eur J Clin Nutr 65(Suppl 1):S102–S107, 2011. research and management, CA Cancer J Clin 52:72–91, 2002.